|Day's Range||200.74 - 202.04|
|52 Week Range||164.80 - 202.04|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.25%|
Skechers, which released its 2Q17 results on July 20, 2017, reported earnings per share of $0.38. The company missed analysts' consensus expectation by a margin of $0.06.
Two top-performing smart beta funds trading near potential buy points are both Europe-focused.
On March 23, 2015, the FDA approved Abiomed’s Impella 2.5 heart pump as a temporary ventricular support device.